Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Biocryst Pharmaceuticals buy JPMorgan Chase & Co.

Biocryst Pharmaceuticals
Start price
€9.37
06.05.25 / 50%
Target price
€11.51
06.05.26
Performance (%)
-30.98%
Price
€6.46
15.12.25
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Biocryst Pharmaceuticals is performing very badly with a performance of -30.98%. This prediction currently runs until 06.05.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Biocryst Pharmaceuticals -2.238% -2.238%
iShares Core DAX® 0.795% 1.458%
iShares Nasdaq 100 -3.088% -0.762%
iShares Nikkei 225® -0.952% -2.268%
iShares S&P 500 -1.393% 0.199%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Biocryst Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) -30.98%
Target price 11.510
Change
Ends at 06.05.26

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at JPMorgan Chase & Co. from $10.00 to $13.00. They now have an "overweight" rating on the stock.
Ratings data for BCRX provided by MarketBeat

JPMorgan Chase & Co. 
0
Report Share
06.05.25

Stopped prediction by JPMorgan_Chase___Co_ for Biocryst Pharmaceuticals

buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€4.86
20.11.23
€9.15
20.11.24
44.15%
21.11.24

JPMorgan Chase & Co. 
20.11.23 50%